Zinger Key Points
- Stephen L. Weiss says UnitedHealth Group has bottomed.
- Sarat Sethi of DCLA loves Salesforce.
- Don't face extreme market conditions unprepared. Get the professional edge with Benzinga Pro's exclusive alerts, news advantage, and volatility tools at 60% (discount ends Wednesday!)
On CNBC's “Halftime Report Final Trades,” Sarat Sethi, managing partner at DCLA, said he loves Salesforce, Inc. CRM.
Supporting his view, Guggenheim analyst John Difucci upgraded Salesforce from Sell to Neutral on Monday.
Stephen L. Weiss of Short Hills Capital Partners chose UnitedHealth Group Incorporated UNH, saying the stock has bottomed.
On the earnings front, UnitedHealth reported first-quarter revenue of $109.58 billion on Monday, missing analyst estimates of $ 111.6 billion, according to Benzinga Pro. The company reported first-quarter adjusted earnings of $7.20 per share, missing estimates of $7.29 per share.
Don't forget to check out our premarket coverage here
Jenny Van Leeuwen Harrington of Gilman Hill Asset Management, LLC, said The Western Union Company WU is being overly sold off due to irrational fears.
After the closing bell on Wednesday, Western Union posted first-quarter adjusted earnings of 41 cents per share, in line with market estimates. The company's sales came in at $983.60 million, missing expectations of $994.64 million.
Joseph M. Terranova of Virtus Investment Partners picked Howmet Aerospace Inc. HWM as his final trade.
Lending support to his choice, Benchmark analyst Josh Sullivan, on Monday, maintained Howmet Aerospace with a Buy rating and raised the price target from $85 to $135.
Price Action:
- Salesforce shares jumped 2.9% to close at $250.48 on Wednesday.
- UnitedHealth gained 0.2% to close at $427.96 during Wednesday's session.
- Western Union shares rose 1.1% to close at $10.11 on Wednesday.
- Howmet Aerospace shares climbed 4.3% to settle at $129.70 during the session.
Photo: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.